Impact of Socio Economic Limitations on Health Outcomes in Patients With Recent Admission for Heart Failure

Heart Failure Clinical Trial

— SELENE  

Official title:

Impact of Socio Economic Limitations on hEalth Outcomes in Patients With Complex and Advanced Chronic Cardiovascular Conditions in High-standard iNtegrated Care Environements (SELENE Study)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04022122
• Other study ID #: IDIBELL-2019/PR157/19
• Status: Completed
• Start date: July 15, 2019
• Est. completion date: January 1, 2023

Study information

• Verified date: October 2023
• Source: Hospital Universitari de Bellvitge
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

To assess the impact of the socio-economic level on the effectiveness of a comprehensive multidisciplinary program of transitional care for crhonic heart failure patients (primary objective); to analyze this specifically in the various chronic management profiles of CHF patients and to study the associations between socio-economic level and other psychosocial aspects (secondary objective).

Description:

The SELENE Study (Impact of SocioEconomic Limitations on health outcomes in patients with complex and advanced chronic cardiovascular conditions in high-standard iNtegrated care Environments) is an observational, cohort, prospective, multicenter study of consecutive patients treated in a comprehensive heart failure (HF) management program, and hospitalized by decompensated HF in our healthcare area; aimed at evaluating the impact of socioeconomic level on the effectiveness of a comprehensive multidisciplinary program of transitional care to patients with HF, both globally and in the various profiles of chronic management of HF.

In this study we aim to assess the impact of the socio-economic level on the effectiveness of a comprehensive multidisciplinary program of transitional care for chronic heart failure patients (primary objective); to analyze this specifically in the various chronic management profiles of HF patients and to study the associations between NSE and other psychosocial aspects (secondary objective).

All patients will have a detailed assessment by a social worker of a battery of psychosocial and functional variables, including educational level, functional status, cognitive status, family support, or the existence of a primary caregiver and an assessment of purchasing power through the value of monthly income. The events that will be analyzed, both for the primary objective of the study and the secondary objective related to the different follow-up profiles, will be re-admissions at 30 days (primary event), and mortality at 30, 90 and 180 days, as well as hospital admission at 90 days and 6 months (secondary events). Using the "median" income group as a reference, comparisons will be made between the rates of these events among the different groups.

The researchers hypothesize that the socioeconomic level has an impact on clinical events of HF patients so that the effectiveness of comprehensive care programs for HF is attenuated in patients with low socioeconomic level.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 121
• Est. completion date: January 1, 2023
• Est. primary completion date: December 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age = 18 years old.

• Patients discharged from a heart failure hospitalization within 30 days of enrollment into the study or in the process of discharge planning.

• Heart Failure diagnosis according to European Society of Cardiology (ESC) criteria.

• Written informed consent must be obtained before any assessment is performed.

• Patients receiving oral standard medication for chronic heart failure (CHF).

• All patients will be eligible regardless the level of left ventricular ejection fraction (LVEF).

Exclusion Criteria:

• Age<18 years old.

• Death before hospital discharge.

• The patient is unable or unwilling to give the informed consent to participate.

• Unstable patients with signs of fluid overload or low cardiac output.

Related Conditions & MeSH terms

• Heart Failure

Intervention

Procedure:
• Usual Care follow-up in a heart failure program.
Standard follow-up involves hospital and primary care for HF patients. In this context, physicians and nurses experienced in the care and management of HF direct care. HF care is based on 1) active detection of newly admitted HF patients, 2) planned educational interventions to improve self-care, 3) completion of a comprehensive psychosocial assessment of patients and caregivers, 4) discharge planning and home transition coordination involving the hospital HF team and Primary Care teams, 5) structured and planned evidence-based follow-up shortly after discharge from hospital.

Locations

Country	Name	City	State
Spain	University Hospital Bellvitge	L'Hospitalet de Llobregat	Barcelona

Sponsors (2)

Lead Sponsor	Collaborator
Hospital Universitari de Bellvitge	Institut d'Investigació Biomèdica de Bellvitge

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Occurrence of cardiovascular death or non-fatal heart failure events	Occurrence of cardiovascular death or non-fatal heart failure events (time to first event) during a follow-up period of 6 months. Non-fatal heart failure event is defined as a new episode of worsening of symptoms and signs consistent with acute decompensated HF requiring intravenous decongestive therapy (e.g. diuretics) either on an outpatient basis (day-case HF hospital) or in the emergency department (<24 hours) or requiring unplanned hospital admission (>24 hours) or complicating the course of a non-cardiovascular admission.	Six months after inclusion of the patient.
Secondary	Readmission (all-cause, HF and cardiovascular) rate and total number.	Comparison of the different socioeconomic levels at the end of follow-up.	Six months after inclusion of the patient.
Secondary	Days in hospital (all-cause, HF and cardiovascular).	Comparison of the different socioeconomic levels at the end of follow-up.	Six months after inclusion of the patient.
Secondary	Rate of emergency visits.	Comparison of the different socioeconomic levels at the end of follow-up.	Six months after inclusion of the patient.
Secondary	Rate of non-fatal HF events.	Comparison of the different socioeconomic levels at the end of follow-up.	Six months after inclusion of the patient.
Secondary	Mortality for any cause and cardiovascular mortality.	Comparison of the different socioeconomic levels at the end of follow-up.	Six months after inclusion of the patient.
Secondary	Change of self-care using a validated scale (European Heart Failure Self-Care Behavior Scale)	Comparison of the different socioeconomic levels at the end of follow-up.	Six months after inclusion of the patient.
Secondary	Change of quality of life using a validated questionnaire (EUROQOL - 5D).	Comparison of the different socioeconomic levels at the end of follow-up.	Six months after inclusion of the patient.
Secondary	Patient satisfaction using a Likert-type scale.	Comparison of the different socioeconomic levels at the end of follow-up.	Six months after inclusion of the patient.